)
Narayana Hrudayalaya (NH) investor relations material
Narayana Hrudayalaya Q2 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q2 FY27 consolidated revenue was ₹28,439.89m, up 73.0% YoY; EBITDA was ₹6,054.15m and continuing-operations net profit ₹3,011.53m.
India hospital growth was driven by higher volumes and price mix; management prioritizes patient access and volume over targeting a specific margin.
International operations are pursuing cost efficiencies and integrated care, with UK revenue recovery and insurance profitability key execution priorities.
H1 FY27 consolidated revenue was ₹55,276.23m, EBITDA ₹11,105.93m and continuing-operations net profit ₹5,084.23m.
Financial highlights
Q2 consolidated EBITDA was ₹6,054.15m, up 42.0% YoY; EBITDA margin was 21.3% versus 25.9% in Q2 FY26.
Continuing-operations net profit was ₹3,011.53m versus ₹2,584.95m a year earlier; net profit margin was 10.59% versus 15.71%.
India hospital EBITDA margin was 26.8%, or 23.6% excluding other income; doctor and nursing costs fell 1.8% through operating leverage.
India inpatient volumes rose 4% YoY and outpatient footfall 12% YoY; inpatient footfall was up 6% QoQ and nearly 4% YoY.
Combined India insurance and clinic losses fell to INR 20 crore from INR 33 crore in the prior quarter; India insurance reported a ₹151m PAT loss in Q2.
Outlook and guidance
Management expects stronger India inpatient and outpatient footfalls in Q3 and Q4, supported by recent volumes and patient funnels across regions.
India average length of stay is targeted to move toward 4.0–4.1 days over four to six quarters, subject to high-acuity and transplant case mix.
UK returns should be assessed over five to seven years; management expects to bridge the 4%–5% group ROCE dilution from the UK over roughly five years.
Cayman plans major insurance repricing in July 2027 and expects to exit most unprofitable books from then; losses are expected to become negligible before that.
Bed capacity target is 7,800+ by FY30; FY27 capex plans are ₹4,600m for greenfield/inorganic projects and ₹2,700m for replacement and maintenance.
- Record revenue, profit, and margin growth with strong expansion and digital transformation.NH
Q4 23/24 - Revenue up 78% YoY, EBITDA at ₹5,052m, India margins strong, U.K. faces short-term disruption.NH
Q1 26/27 - FY26 revenue up 44% YoY, strong margins, UK expansion, and ₹4.50 dividend proposed.NH
Q4 25/26 - Q3 FY26 delivered 61.2% YoY revenue growth, robust expansion, and UK integration.NH
Q3 25/26 - Q1 FY25 saw record revenue, margin expansion, and new health insurance operations amid robust growth.NH
Q1 24/25 - Q2 FY25 delivered revenue growth, margin gains, digital progress, and 1,500 new beds planned.NH
Q2 24/25 - Q3 FY25 saw robust growth, margin gains, digital progress, and disciplined expansion.NH
Q3 24/25 - Strong FY25 revenue and EBITDA growth, dividend, NCD issuance, and expansion plans.NH
Q4 24/25 - Q1 FY26 delivered strong revenue and margin growth, with expansion and digitalization ongoing.NH
Q1 25/26
Next Narayana Hrudayalaya earnings date
Next Narayana Hrudayalaya earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)